Business Weekly newspaper
@businessweekly.bsky.social
📤 46
đź“Ą 71
đź“ť 15
Cambridge and East of England, UK business news. www.businessweekly.co.uk
Cambridge-based Congenica is being acquired for an undisclosed sum by French company SeqOne but the new entity will retain a base at the Wellcome Sanger Institute from where it was spun out. Full article –
www.businessweekly.co.uk/posts/seqone...
loading . . .
SeqOne in France buying Sanger spin-out Congenica to create world leader in AI-powered genomic medicine
Cambridge-based Congenica is being acquired for an undisclosed sum by French company SeqOne but the new entity will retain a base at the Wellcome Sanger Institute from where it was spun out.
https://www.businessweekly.co.uk/posts/seqone-in-france-buying-sanger-spin-out-congenica-to-create-world-leader-in-ai-powered
4 months ago
0
0
0
The first resource containing high-resolution DNA sequencing data for over 37,000 children and parents collected over multiple decades from across the UK is now available to researchers worldwide.
@sangerinstitute.bsky.social
Full article –
www.businessweekly.co.uk/posts/decade...
loading . . .
Decades of DNA sequencing data from UK child development study released
The first resource containing high-resolution DNA sequencing data for over 37,000 children and parents collected over multiple decades from across the UK is now available to researchers worldwide. The...
https://www.businessweekly.co.uk/posts/decades-of-dna-sequencing-data-from-uk-child-development-study-released
10 months ago
0
1
0
For DeepTech funder Cambridge Innovation Capital, it’s a case of back to the future after its decision to take venture builder Start Codon under its management.
www.businessweekly.co.uk/posts/cambri...
loading . . .
Cambridge Innovation Capital to curate Start Codon future
For DeepTech funder Cambridge Innovation Capital, it’s a case of back to the future after its decision to take venture builder Start Codon under its management. CIC Partner Michael Anstey, who special...
https://www.businessweekly.co.uk/posts/cambridge-innovation-capital-to-curate-start-codon-future
10 months ago
0
2
1
Sortera Bio Ltd has spun out of the Medical Research Council Laboratory of Molecular Biology (MRC LMB) to pioneer a Deep Screening platform set to redefine early biologics discovery and engineering.
www.businessweekly.co.uk/posts/sorter...
loading . . .
Sortera Bio spins out of MRC LMB with revolutionary tech
Sortera Bio Ltd has spun out of the Medical Research Council Laboratory of Molecular Biology (MRC LMB) to pioneer a Deep Screening platform set to redefine early biologics discovery and engineering. I...
https://www.businessweekly.co.uk/posts/sortera-bio-spins-out-of-mrc-lmb-with-revolutionary-tech
10 months ago
0
0
0
ExpressionEdits in Cambridge has clinched unspecified riches from Boehringer Ingelheim through a collaboration and licensing agreement. Boehringer will leverage ExpressionEdits’ Genetic Syntax Engine for two gene therapy targets.
www.businessweekly.co.uk/posts/expres...
loading . . .
ExpressionEdits and Boehringer Ingelheim collaborate to enhance gene therapies
ExpressionEdits in Cambridge has clinched unspecified riches from global pharmaceutical company Boehringer Ingelheim through a collaboration and licensing agreement.
https://www.businessweekly.co.uk/posts/expressionedits-and-boehringer-ingelheim-collaborate-to-enhance-gene-therapies
10 months ago
0
0
0
Cambridge Consultants, a subsidiary of Capgemini SE, is the brains behind a new generative AI-driven methodology for protein engineering that uses a specialised protein large language model (pLLM) to predict the most effective protein variants.
www.businessweekly.co.uk/posts/cambri...
loading . . .
Cambridge Consultants brainpower sparks protein engineering AI revolution
Cambridge Consultants, which is a DeepTech powerhouse subsidiary of French company Capgemini SE, is the brains behind a cutting edge advancement in generative AI.
https://www.businessweekly.co.uk/posts/cambridge-consultants-brainpower-sparks-protein-engineering-ai-revolution
10 months ago
0
0
0
US MedTech company ClariMed Inc. has opend a study facility in Cambridge UK to advance human factors
#research
capabilities, expanding its capacity to host and conduct research to support user-centered medical device development. Full article –
www.businessweekly.co.uk/posts/clarim...
loading . . .
ClariMed opens research facility in Cambridge
US MedTech company ClariMed Inc. has unveiled a new study facility in Cambridge to advance human factors research capabilities.
https://www.businessweekly.co.uk/posts/clarimed-opens-research-facility-in-cambridge
10 months ago
0
1
0
Qureight and Avalyn Pharma join forces to combat pulmonary fibrosis
www.businessweekly.co.uk/posts/qureig...
loading . . .
Qureight and Avalyn join forces to combat pulmonary fibrosis
A transatlantic Cambridge2Cambridge alliance between Qureight in the UK and Avalyn Pharma Inc in Massachusetts – is seeking to improve treatment of pulmonary fibrosis (PPF) for which there is currentl...
https://www.businessweekly.co.uk/posts/qureight-and-avalyn-join-forces-to-combat-pulmonary-fibrosis
10 months ago
0
0
0
Are we thinking we are back? – Guest article by Tony Jones, CEO of One Nucleus
www.businessweekly.co.uk/posts/are-we...
loading . . .
Are we thinking we are back?
Since the heady highs of investment during the Covid years, it has been extremely challenging in terms of the funding environment for the region’s life science companies, impacting all stakeholders – ...
https://www.businessweekly.co.uk/posts/are-we-thinking-we-are-back
10 months ago
0
0
0
New screening device shows promise for early lung cancer detection
www.businessweekly.co.uk/posts/new-sc...
loading . . .
New screening device shows promise for early lung cancer detection
Cranfield University scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even bef...
https://www.businessweekly.co.uk/posts/new-screening-device-shows-promise-for-early-lung-cancer-detection
10 months ago
0
0
0
Solid gold future as Astex pursues further growth in wake of silver jubilee
www.businessweekly.co.uk/posts/solid-...
loading . . .
Solid gold future as Astex pursues further growth in wake of silver jubilee
Cambridge biotech company Astex belatedly celebrated its 25th anniversary in style with UK Science Minister and new trade tsar Lord Vallance leading the salutes at the company’s Science Park HQ.
https://www.businessweekly.co.uk/posts/solid-gold-future-as-astex-pursues-further-growth-in-wake-of-silver-jubilee
10 months ago
0
0
0
VasoDynamics: Born of sadness but designed to generate many happy outcomes
www.businessweekly.co.uk/posts/vasody...
loading . . .
VasoDynamics: Born of sadness but designed to generate many happy outcomes
Fiona Li learned early how cancer could end a life and devastate others within a circle of family or friends. She and a friend were inseparable. They would walk to and from school hand in hand, smilin...
https://www.businessweekly.co.uk/posts/vasodynamics-born-of-sadness-but-designed-to-generate-many-happy-outcomes
10 months ago
0
0
0
Nasdaq shares climb as Arm posts record Q3 results and soaring chip demand
www.businessweekly.co.uk/posts/nasdaq...
loading . . .
Nasdaq shares climb as Arm posts record Q3 results and soaring chip demand
Cambridge UK superchip architect Arm saw its stock on the Nasdaq market in the US climb almost seven per cent and $11 to $173.26 after posting record Q3 revenues. Its market cap hit $182.10 billion.
https://www.businessweekly.co.uk/posts/nasdaq-shares-climb-as-arm-posts-record-q3-results-and-soaring-chip-demand
10 months ago
0
0
0
Paragraf and University of Cambridge in graphene tech advance
www.businessweekly.co.uk/posts/paragr...
loading . . .
Paragraf and University of Cambridge in graphene tech advance
Paragraf, which is pioneering the mass production of graphene-based electronics with standard semiconductor processes, has been awarded a grant of cÂŁ420k from Innovate UK to produce a proof-of-concept...
https://www.businessweekly.co.uk/posts/paragraf-and-university-of-cambridge-in-graphene-tech-advance
10 months ago
0
0
0
AstraZeneca leads FTSE charge with shares surge and higher dividend
www.businessweekly.co.uk/posts/astraz...
loading . . .
AstraZeneca leads FTSE charge with shares surge and higher dividend
Some market watchers had a quiet chuckle when Cambridge-based pharmaceutical giant AstraZeneca said it was targeting $80 billion total revenue by the end of the decade. They’re not laughing now!
https://www.businessweekly.co.uk/posts/astrazeneca-leads-ftse-charge-with-shares-surge-and-higher-dividend
10 months ago
0
0
0
you reached the end!!
feeds!
log in
